Evoke (LON:EVOK) Shares Down 20.9% – Should You Sell?

Evoke plc (LON:EVOKGet Free Report) traded down 20.9% during mid-day trading on Wednesday . The company traded as low as GBX 56 ($0.73) and last traded at GBX 56.50 ($0.73). 8,039,770 shares were traded during mid-day trading, an increase of 291% from the average session volume of 2,054,730 shares. The stock had previously closed at GBX 71.40 ($0.92).

Analyst Upgrades and Downgrades

A number of research analysts recently weighed in on EVOK shares. Berenberg Bank lowered their target price on shares of Evoke from GBX 130 ($1.68) to GBX 90 ($1.17) and set a “buy” rating on the stock in a research note on Wednesday, December 4th. Jefferies Financial Group restated a “buy” rating and issued a GBX 140 ($1.81) price objective on shares of Evoke in a research report on Monday, December 16th.

Get Our Latest Stock Report on EVOK

Evoke Stock Performance

The stock has a market cap of £223.22 million, a P/E ratio of -1.25 and a beta of 0.84. The stock’s fifty day moving average is GBX 69.32 and its 200 day moving average is GBX 63.58.

Evoke (LON:EVOKGet Free Report) last announced its earnings results on Wednesday, March 26th. The company reported GBX (6.40) (($0.08)) EPS for the quarter. Evoke had a negative return on equity of 517.98% and a negative net margin of 8.50%. Equities research analysts predict that Evoke plc will post 12.7648305 EPS for the current year.

Insiders Place Their Bets

In other news, insider Andrea Gisle Joosen acquired 14,572 shares of the firm’s stock in a transaction on Tuesday, January 28th. The stock was acquired at an average price of GBX 70 ($0.91) per share, with a total value of £10,200.40 ($13,206.11). 27.00% of the stock is owned by insiders.

Evoke Company Profile

(Get Free Report)

Recommended Stories

Receive News & Ratings for Evoke Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evoke and related companies with MarketBeat.com's FREE daily email newsletter.